Susquehanna International Group, LLP Allogene Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.08 - $3.5 $82,368 - $138,600	-39,600 Reduced 49.13%	41,000 $114,000
Q2 2024 Aug 15, 2024	SELL	$2.23 - $4.38 $31,666 - $62,196	-14,200 Reduced 14.98%	80,600 $187,000
Q1 2024 May 07, 2024	BUY	$2.92 - $5.63 $276,816 - $533,724	94,800 New	94,800 $423,000
Q1 2023 May 16, 2023	SELL	$4.92 - $8.21 $43,788 - $73,069	-8,900 Reduced 41.2%	12,700 $62,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $5,620 - $11,110	-1,000 Reduced 4.42%	21,600 $135,000
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $155,832 - $260,928	-15,100 Reduced 40.05%	22,600 $244,000
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $182,382 - $330,332	-26,900 Reduced 41.64%	37,700 $430,000
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $227,205 - $454,113	29,700 Added 85.1%	64,600 $589,000
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $3,939 - $7,356	-300 Reduced 0.85%	34,900 $521,000
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $350,867 - $461,588	16,700 Added 90.27%	35,200 $905,000
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $1.5 Million - $2.27 Million	-58,100 Reduced 75.85%	18,500 $653,000
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $1.38 Million - $1.91 Million	-42,500 Reduced 35.68%	76,600 $2.89 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $1.44 Million - $4.24 Million	78,400 Added 192.63%	119,100 $5.1 Million
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $105,676 - $163,850	-5,800 Reduced 12.47%	40,700 $791,000
Q4 2019 Feb 14, 2020	SELL	$24.82 - $31.4 $4.11 Million - $5.2 Million	-165,700 Reduced 78.09%	46,500 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $3.97 Million - $5.01 Million	152,000 Added 252.49%	212,200 $5.78 Million
Q2 2019 Aug 14, 2019	BUY	$25.56 - $31.09 $237,708 - $289,137	9,300 Added 18.27%	60,200 $1.62 Million
Q1 2019 May 15, 2019	BUY	$24.82 - $32.54 $876,146 - $1.15 Million	35,300 Added 226.28%	50,900 $1.47 Million
Q4 2018 Feb 14, 2019	BUY	$22.5 - $33.3 $351,000 - $519,479	15,600 New	15,600 $420,000

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $315M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account